InsidersTradesSigma
Track the 서울제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 서울제약 has recorded 2 public disclosures. The latest transaction was disclosed on 30 November 2022 (Purchase). Among the most active insiders: 신봉환. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
서울제약 是一家在XKRX市场上市的医疗保健和制药公司。它专注于药品的制造和分销。